These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37451146)

  • 1. Fragment merging approach for the design of thiazole/thiazolidine clubbed pyrazoline derivatives as anti-inflammatory agents: Synthesis, biopharmacological evaluation and molecular modeling studies.
    Elgohary MK; Abd El Hadi SR; Abo-Ashour MF; Abo-El Fetoh ME; Afify H; Abdel-Aziz HA; Abou-Seri SM
    Bioorg Chem; 2023 Oct; 139():106724. PubMed ID: 37451146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation and docking study of 1,3,4-thiadiazole-thiazolidinone hybrids as anti-inflammatory agents with dual inhibition of COX-2 and 15-LOX.
    Omar YM; Abdu-Allah HHM; Abdel-Moty SG
    Bioorg Chem; 2018 Oct; 80():461-471. PubMed ID: 29986191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes.
    Maghraby MT; Abou-Ghadir OMF; Abdel-Moty SG; Ali AY; Salem OIA
    Bioorg Med Chem; 2020 Apr; 28(7):115403. PubMed ID: 32127262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations.
    Mohammed ER; Abd-El-Fatah AH; Mohamed AR; Mahrouse MA; Mohammad MA
    Bioorg Chem; 2024 Jun; 147():107372. PubMed ID: 38653152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and mechanistic study of novel diarylpyrazole derivatives as anti-inflammatory agents with reduced cardiovascular side effects.
    Amin NH; Hamed MIA; Abdel-Fattah MM; Abusabaa AHA; El-Saadi MT
    Bioorg Chem; 2021 Nov; 116():105394. PubMed ID: 34619468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 and 15-lipoxygenase inhibition, synthesis, anti-inflammatory activity and ulcer liability of new celecoxib analogues: Determination of region-specific pyrazole ring formation by NOESY.
    Abdelall EKA; Lamie PF; Ali WAM
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2893-2899. PubMed ID: 27158139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids.
    Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R
    Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of new thymol-3,4-disubstituted thiazole hybrids as dual COX-2/5-LOX inhibitors with
    El-Miligy MMM; Al-Kubeisi AK; Nassra RA; El-Zemity SR; Hazzaa AA
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2309171. PubMed ID: 38291670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors.
    Reddy MV; Billa VK; Pallela VR; Mallireddigari MR; Boominathan R; Gabriel JL; Reddy EP
    Bioorg Med Chem; 2008 Apr; 16(7):3907-16. PubMed ID: 18272371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition.
    Ghanim AM; Rezq S; Ibrahim TS; Romero DG; Kothayer H
    Eur J Med Chem; 2021 Jul; 219():113457. PubMed ID: 33892270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailored quinoline hybrids as promising COX-2/15-LOX dual inhibitors endowed with diverse safety profile: Design, synthesis, SAR, and histopathological study.
    Hegazy ME; Taher ES; Ghiaty AH; Bayoumi AH
    Bioorg Chem; 2024 Apr; 145():107244. PubMed ID: 38428284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazoles and Thiazolidinones as COX/LOX Inhibitors.
    Liaras K; Fesatidou M; Geronikaki A
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29562646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of new pyrazoloquinazoline derivatives as dual COX-2/5-LOX inhibitors.
    Shaaban MA; Kamal AM; Faggal SI; Farag NA; Aborehab NM; Elsahar AE; Mohamed KO
    Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000027. PubMed ID: 32696514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of new multitarget-directed ligands containing thienopyrimidine nucleus for inhibition of 15-lipoxygenase, cyclooxygenases, and pro-inflammatory cytokines.
    Abdelkhalek AS; Kothayer H; Rezq S; Orabi KY; Romero DG; El-Sabbagh OI
    Eur J Med Chem; 2023 Aug; 256():115443. PubMed ID: 37182334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and development of thiazole leads as COX-2/5-LOX inhibitors through in-vitro and in-vivo biological evaluation for anti-inflammatory activity.
    Jacob P J; Manju SL
    Bioorg Chem; 2020 Jul; 100():103882. PubMed ID: 32361295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors.
    Lamie PF; Philoppes JN; Rárová L
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
    Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
    Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1,2/5-LOX inhibition and docking study.
    Abdelgawad MA; Labib MB; Abdel-Latif M
    Bioorg Chem; 2017 Oct; 74():212-220. PubMed ID: 28865292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors.
    Gedawy EM; Kassab AE; El Kerdawy AM
    Eur J Med Chem; 2020 Mar; 189():112066. PubMed ID: 31982653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of isoxazolo[4,5-d]pyridazin-4-(5H)-one analogues as potent anti-inflammatory agents.
    Özadalı K; Özkanlı F; Jain S; Rao PP; Velázquez-Martínez CA
    Bioorg Med Chem; 2012 May; 20(9):2912-22. PubMed ID: 22475926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.